Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann W Morgan

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Rheumatology (Oxford, England)|April 4, 2022
Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapyMegan Sutcliffe, Nisha Nair, James Oliver, et al.
Human Mutation|February 1, 2012
Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritisJames I Robinson, Ian M Carr, Dawn L Cooper, et al.
Arthritis Research & Therapy|July 31, 2015
Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigationSarah Louise Mackie, John C Taylor, Lubna Haroon-Rashid, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patientsLydia R Coulthard, John C Taylor, Steve Eyre, et al.
Annals of the Rheumatic Diseases|March 24, 2012
Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional studySarah L Mackie, John C Taylor, Sarah Twigg, et al.
Pharmaceutics|June 27, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid ArthritisStephanie F Ling, Kayode Ogungbenro, Adam S Darwich, et al.
Arthritis Research & Therapy|April 1, 2010
Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohortAnn W Morgan, James I Robinson, Philip G Conaghan, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritisNatalie J M Chaddock, Charlotte J Harden, Louise Sorensen, et al.
Annals of the Rheumatic Diseases|October 3, 2024
Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritisNatalie J M Chaddock, Charlotte J Harden, Louise Sorensen, et al.
Genetic Epidemiology|October 13, 2018
Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP dataSvetlana Cherlin, Darren Plant, John C Taylor, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Rheumatology (Oxford, England)|April 4, 2022
Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapyMegan Sutcliffe, Nisha Nair, James Oliver, et al.
Human Mutation|February 1, 2012
Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritisJames I Robinson, Ian M Carr, Dawn L Cooper, et al.
Arthritis Research & Therapy|July 31, 2015
Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigationSarah Louise Mackie, John C Taylor, Lubna Haroon-Rashid, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patientsLydia R Coulthard, John C Taylor, Steve Eyre, et al.
Annals of the Rheumatic Diseases|March 24, 2012
Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional studySarah L Mackie, John C Taylor, Sarah Twigg, et al.
Pharmaceutics|June 27, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid ArthritisStephanie F Ling, Kayode Ogungbenro, Adam S Darwich, et al.
Arthritis Research & Therapy|April 1, 2010
Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohortAnn W Morgan, James I Robinson, Philip G Conaghan, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritisNatalie J M Chaddock, Charlotte J Harden, Louise Sorensen, et al.
Annals of the Rheumatic Diseases|October 3, 2024
Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritisNatalie J M Chaddock, Charlotte J Harden, Louise Sorensen, et al.
Genetic Epidemiology|October 13, 2018
Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP dataSvetlana Cherlin, Darren Plant, John C Taylor, et al.
Pageof 14